Sartorius/€SRT3
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Sartorius
Sartorius AG, trading under the ticker symbol SRT3, is a global provider of laboratory and bioprocess technologies, offering products and services that cater to the needs of the biopharmaceutical and research industries. Founded in 1870 and headquartered in Göttingen, Germany, the company specializes in filtration, fermentation, fluid management, and laboratory products, supporting clients ranging from research facilities to large-scale biopharmaceutical manufacturers. Operating internationally, Sartorius is crucial in enabling the development and production of biotech medications and vaccines, solidifying its role as a crucial player in the life sciences and biotechnology sectors.
Ticker
€SRT3
Sector
Primary listing
XETRA
Employees
13,671
Headquarters
Website
Sartorius Metrics
BasicAdvanced
€13B
91.78
€2.24
1.52
€0.74
0.36%
Price and volume
Market cap
€13B
Beta
1.52
52-week high
€266.90
52-week low
€166.05
Average daily volume
3.6K
Dividend rate
€0.74
Financial strength
Current ratio
0.898
Quick ratio
0.427
Long term debt to equity
86.781
Total debt to equity
110.736
Dividend payout ratio (TTM)
32.73%
Interest coverage (TTM)
3.30%
Profitability
EBITDA (TTM)
886.1
Gross margin (TTM)
46.26%
Net profit margin (TTM)
4.38%
Operating margin (TTM)
16.04%
Effective tax rate (TTM)
31.61%
Revenue per employee (TTM)
€260,000
Management effectiveness
Return on assets (TTM)
3.58%
Return on equity (TTM)
5.93%
Valuation
Price to earnings (TTM)
91.778
Price to revenue (TTM)
4.018
Price to book
4.73
Price to tangible book (TTM)
-5.78
Price to free cash flow (TTM)
35.982
Free cash flow yield (TTM)
2.78%
Free cash flow per share (TTM)
5.722
Dividend yield (TTM)
0.36%
Forward dividend yield
0.36%
Growth
Revenue change (TTM)
4.66%
Earnings per share change (TTM)
84.22%
3-year revenue growth (CAGR)
-5.37%
10-year revenue growth (CAGR)
12.24%
3-year earnings per share growth (CAGR)
-39.06%
10-year earnings per share growth (CAGR)
1.94%
3-year dividend per share growth (CAGR)
-19.90%
10-year dividend per share growth (CAGR)
7.18%
What the Analysts think about Sartorius
Analyst ratings (Buy, Hold, Sell) for Sartorius stock.
Sartorius Financial Performance
Revenues and expenses
Sartorius Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Sartorius stock?
Sartorius (SRT3) has a market cap of €13B as of March 23, 2026.
What is the P/E ratio for Sartorius stock?
The price to earnings (P/E) ratio for Sartorius (SRT3) stock is 91.78 as of March 23, 2026.
Does Sartorius stock pay dividends?
Yes, the Sartorius (SRT3) stock pays dividends to shareholders. As of March 23, 2026, the dividend rate is €0.74 and the yield is 0.36%. Sartorius has a payout ratio of 32.73% on a trailing twelve-month basis.
When is the next Sartorius dividend payment date?
The next Sartorius (SRT3) dividend payment is scheduled for March 31, 2026.
What is the beta indicator for Sartorius?
Sartorius (SRT3) has a beta rating of 1.52. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.